You have no items in your shopping cart.
On Promotion
Category
Tested Applications
Reactivity
Conjugation
Biologically Active
Featured Product
Search results for: 'recombinant'
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 110.4 KDa. Observed: 150-160 KDa, reducing conditions
Human
Ala20-Glu764
C-Fc
500 μg, 10 μg, 50 μg, 1 mgUnconjugated
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 45.5 KDa. Observed: 60-80 KDa, reducing conditions
Human
Leu23-Gly434
C-6His
10 μg, 50 μg, 1 mg, 500 μgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 45.47 KDa. Observed: 50-60 KDa, reducing conditions
Mouse
Gln39-Val207
C-Fc
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 51.9 KDa. Observed: 72-90 KDa, reducing conditions
Mouse
Phe19-Thr238
C-Fc
1 mg, 10 μg, 50 μg, 500 μgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 25.6 KDa. Observed: 39-58 KDa, reducing conditions
Mouse
Phe19-Thr238
C-6His
1 mg, 10 μg, 50 μg, 500 μgUnconjugated
SDS-PAGE: Greater than 85% as determined by reducing SDS-PAGE.(QC verified). SEC-HPLC: Greater than 90% as determined by SEC-HPLC.(QC verified)
Predicted: 22.3 KDa. Observed: 30-40 KDa, reducing conditions
Mouse
Pro26-Thr211
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 51.7 KDa. Observed: 60-80 KDa, reducing conditions
Human
Ala27-Asp239
C-Fc
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SEC-HPLC: Greater than 90% as determined by SEC-HPLC.(QC verified)
Predicted: 25.6 KDa. Observed: 35-40 KDa, reducing conditions
Human
Ala27-Asp239
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.. SEC-HPLC: Greater than 90% as determined by SEC-HPLC. (QC verified)
Predicted: 48.9 KDa. Observed: 60-80 KDa, reducing conditions
Human
Glu22-Cys213
C-Fc
50 μg, 10 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 22.8 KDa. Observed: 35-44 KDa, reducing conditions
Human
Glu22-Cys213
C-6His
10 μg, 50 μg, 500 μg, 1 mg